drugset
drugset / Trial / NCT01886937

Studying the Effects of Phentermine on Eating Behavior

NCT01886937 ↗

Phase 4 Completed 13 enrolled New York State Psychiatric Institute AstraZeneca · collab
RandomizedCrossoverDouble-blindOther

Summary

The goal of this study is to determine whether one week of phentermine compared to placebo administration results in changes in food intake during a laboratory meal.

Timeline

Start
2012-07
Primary completion
2014-06
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Phentermine Small molecule 37.5 mg —

Indications

obesity disorder